Vertex Pharmaceuticals
VRTX
VRTX
852 hedge funds and large institutions have $58.4B invested in Vertex Pharmaceuticals in 2020 Q1 according to their latest regulatory filings, with 133 funds opening new positions, 329 increasing their positions, 275 reducing their positions, and 86 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
852
Holders Change
+40
Holders Change %
+4.93%
% of All Funds
18.82%
Holding in Top 10
32
Holding in Top 10 Change
+14
Holding in Top 10 Change %
+77.78%
% of All Funds
0.71%
New
133
Increased
329
Reduced
275
Closed
86
Calls
$306M
Puts
$264M
Net Calls
+$42.4M
Net Calls Change
+$61.7M
Top Buyers
| 1 |
Capital World Investors
Los Angeles,
California
|
+$472M |
| 2 |
BlackRock
New York
|
+$288M |
| 3 |
Jennison Associates
New York
|
+$188M |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
+$167M |
| 5 |
GQG Partners
Ft. Lauderdale,
Florida
|
+$150M |
Top Sellers
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$691M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$287M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$139M |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$127M |
| 5 |
SIG
Senator Investment Group
New York
|
-$98.5M |
